Everyone is entitled to their opinion on this forum. However, you just cannot make things up and post clearly misleading and untrue statements such as what you’ve just done:
’It was a shame they didn’t continue the trial at the lower doses that had proved well tolerated and efficacious’ ~ @bid
There were plenty of adverse events related to treatment early in the trials at lower doses and throughout the trials at higher doses evidenced as far back as 2022 from the first AstraZeneca poster presentation.
AstraZeneca reported on multiple occasions that none of the patients had met the formal criteria of a response.
You appear to be just making things up. Do better.
Ann: Starpharma and Medicxi Partnership Petalion Therapeutics, page-158
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.002(2.04%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.9¢ | 10.5¢ | 9.9¢ | $49.15K | 486.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65751 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 226460 | 3 |
View Market Depth
| Last trade - 16.10pm 02/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |